Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer

^*Corresponding author for this work

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 28 Sept 2016

Access to Document

@book{8202e0faf84343d8a9080052cde5845c,

title = "Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer",

author = "Robert Hodgson and Mousumi Biswas and Morgan, {Philip James} and Teumzghi Mebrahtu and Melissa Harden and Woolacott, {Nerys Frances}",

year = "2016",

month = sep,

day = "28",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer

AU - Hodgson, Robert

AU - Biswas, Mousumi

AU - Morgan, Philip James

AU - Mebrahtu, Teumzghi

AU - Harden, Melissa

AU - Woolacott, Nerys Frances

PY - 2016/9/28

Y1 - 2016/9/28

M3 - Commissioned report

BT - Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer

PB - National Institute for Health and Care Excellence

ER -